improving Oncology Research with built-in KRAS Assay Services and RAS Assays
within the swiftly evolving field of oncology study, correct and successful mutation screening is very important for producing specific therapies. The KRAS Services Platform plays a pivotal function On this landscape by offering complete options for KRAS mutation profiling and Examination. KRAS mutations, present in around 95% of RAS-similar oncoge